$RNA
Atrium Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$9.08
▼-5.02%-$0.480
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAtrium Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RNA down today? It is at $9.08 (-5.02%), and our scanner flagged it 42 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNA spikes, and full due diligence on RNA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNA 42 times in the last 30 days. Create a free account to track $RNA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RNA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAtrium Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Younis Husam Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 53K | n/a | Apr 20, 26 |
Hoyos Rocio Martin Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 47K | n/a | Apr 20, 26 |
Gallagher Kathleen P. Officer | Acquired (grant/award) | +103K 0.6% of company | added 100% | 131K | n/a | Apr 20, 26 |
Winslow Brendan R. Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 44K | n/a | Apr 20, 26 |
Hughes Steven George Officer | Acquired (grant/award) | +30K 0.2% of company | added 70% | 73K | n/a | Apr 20, 26 |
Kenney Stephanie Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 35K | n/a | Apr 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RNA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RNA last traded at $9.08, down 5.02% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Atrium Therapeutics, Inc. Common Stock (RNA) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RNA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNA 42 times in the last 30 days.
RNA (Atrium Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $153M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNA discussion
Sign in to ask a question or join the discussion.